Australia markets open in 54 minutes

NVDA Mar 2025 1160.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
153.30-1.93 (-1.24%)
As of 02:44PM EDT. Market open.
Full screen
Previous close155.23
Open153.30
Bid150.40
Ask152.25
Strike1,160.00
Expiry date2025-03-21
Day's range153.30 - 153.30
Contract rangeN/A
Volume1
Open interest40
  • Yahoo Finance Video

    Crypto under pressure, Good Buy or Goodbye: Market Domination

    On today's episode of Market Domination, Hosts Julie Hyman and Josh Lipton discuss major market trends from Nvidia's (NVDA) slowdown to Novo Nordisk's (NVO) plans to expand manufacturing capabilities of its GLP-1 weight-loss drugs. As Nvidia continues on its downward trajectory after leading the S&P 500's (^GSPC) growth, B. Riley Wealth Chief Market Strategist Art Hogan believes the market can keep up its momentum without the chip giant: "I think it's a perfect example of a lot of folks being concerned that Nvidia and arguably Nvidia, Microsoft (MSFT), and Apple (AAPL) were such a big part of the 15% that the S&P 500 is higher this year on a year to date basis... But you're seeing basically three or four days where Nvidia has not been leading the charge, and the market's done very well. I think that continues throughout the second half of this year." The European Union has charged Apple under its Digital Markets Act, alleging that the tech giant's App Store practices prevent app developers from directing consumers to cheaper services. TECHnalysis Research President and Chief Analyst Bob O'Donnell believes the investigation is unlikely to conclude anytime soon, and that Apple will have to make some changes: "I do think Apple is going to have to make some tweaks, some things that they don't necessarily want to do, but at the end of the day, again, it's an important enough market that they're going to have to follow some of these requirements that the EU is putting into place. And therefore, long term, I don't think the impact is that big of a deal as far as the value of the company and the way people view the stock." Cryptocurrencies are also under pressure, with bitcoin (BTC-USD) having its worst trading day since March. Meanwhile, the health industry is making major moves, as Altimmune (ALT) reported positive results in Phase 2 trials for its weight-loss drug, a Teladoc Health (TDOC) study showed its AI models contributed to positive growth in diabetes management, and Novo Nordisk revealed plans to invest $4.1 billion in building out a manufacturing facility in Clayton, North Carolina for its GLP-1 weight-loss drugs. This post was written by Melanie Riehl

  • Yahoo Finance

    Nvidia stock falls more than 6% as investors rotate out of chip heavyweight

    Nvidia slipped into correction territory as investors rotated out of AI's hottest play of the year.

  • Yahoo Finance Video

    Tech undergoing 'continued growth story' despite Nvidia drag

    Nvidia's (NVDA) stock slump — down by 9% over the last five trading days — dragging down tech-heavy indexes (^DJI, ^IXIC, ^GSPC) along with it. Yahoo Finance's The Morning Brief welcomes Commonwealth Financial Network CIO Brad McMillan to talk about recent trends in the tech sector and major chip players. "When you look at the underlying trends, there are some companies coming up underneath Nvidia in the in the artificial intelligence [AI] market. But at the same time Nvidia is still amazingly dominant," McMillan explains. "So, you know a little bit of a pullback, that doesn't worry me necessarily in the short term as long as the trends remain positive and they are. And those other companies give you other opportunities going forward." McMillan also weighs in on opportunities in small-cap stocks (^RUT) and the Federal Reserve's interest rate approach to inflation. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.